Developer of biopharmaceutical drugs designed to advance targeted therapies for cancer and other serious diseases. Coherent Biopharma is based in Suzhou, China. It has raised $130 million.
PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$130.0M
Last round
—
Team — not yet on record
No current team members for Coherent Biopharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Coherent Biopharma with a free account
·Watch Coherent Biopharma: the Monday email on marks, rounds and moves
